Clinical Trial Update: Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical Study [Phase 2]

View source ↗

Summary

This document reports a Phase II clinical trial of Endostar for peripheral T-cell lymphoma sponsored by Nanjing NingQi Medicine Science and Technology Co., Ltd.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Endostar (recombinant human endostatin)

Snippet

Sponsor: Nanjing NingQi Medicine Science and Technology Co., Ltd. | Conditions: Peripheral T-cell Lymphomas | Phase 2 | Status: UNKNOWN